PepGen (PEPG) Net Equity Issued and Repurchased (2021 - 2026)

PepGen (PEPG) reported Net Equity Issued and Repurchased of $1.5 million for Q1 2026, down 84.74% sequentially from $9.9 million in Q1 2024.

PepGen (PEPG) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

PepGen (PEPG) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $1.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (changed N/A YoY), and the FY2024 full-year result was $9.9 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased retreated to $1.5 million in Q1 2026, from $9.9 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $9.9 million in Q1 2024 to a low of $1.5 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 PepGen 145.09 Mn 145.09 Mn - 1.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.51 Mn
Mar 31, 2026 1.51 Mn
Mar 31, 2024 9.90 Mn
Mar 31, 2024 9.90 Mn
Dec 31, 2021 -75.14 Mn
Dec 31, 2021 -75.14 Mn
Sep 30, 2021 96.11 Mn
Sep 30, 2021 96.11 Mn